دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Neurology and the climate emergency
doi : 10.1016/S1474-4422(21)00429-4
Volume 21, Issue 1, January 2022, Page 1
Stroke research in 2021: insights into the reorganisation of stroke care
LaurentPuyaCharlotteCordonniera
doi : 10.1016/S1474-4422(21)00410-5
Volume 21, Issue 1, January 2022, Pages 2-3
2021 marks a new era for Alzheimer's therapeutics
KejalKantarcia
doi : 10.1016/S1474-4422(21)00412-9
Volume 21, Issue 1, January 2022, Pages 3-4
Highlights in traumatic brain injury research in 2021
JenniePonsfordabGershonSpitzabAmelia JHicksab
doi : 10.1016/S1474-4422(21)00424-5
Volume 21, Issue 1, January 2022, Pages 5-6
Headache in 2021: clinical, biological, and genetic advances
RobertoDe IccoabCristinaTassorelliab
doi : 10.1016/S1474-4422(21)00425-7
Volume 21, Issue 1, January 2022, Pages 6-8
Epilepsy research in 2021: multidisciplinary achievements
AkioIkedaa
doi : 10.1016/S1474-4422(21)00421-X
Volume 21, Issue 1, January 2022, Pages 8-10
Movement disorders research in 2021: cracking the paradigm
Alberto JEspaya
doi : 10.1016/S1474-4422(21)00413-0
Volume 21, Issue 1, January 2022, Pages 10-11
Multiple sclerosis in 2021: progress against progression
Erin SBeckaDaniel SReichb
doi : 10.1016/S1474-4422(21)00417-8
Volume 21, Issue 1, January 2022, Pages 12-13
Major research advances in amyotrophic lateral sclerosis in 2021
SusannePetria
doi : 10.1016/S1474-4422(21)00420-8
Volume 21, Issue 1, January 2022, Pages 14-15
Important advances in sleep research in 2021
Leslie CWestaClete AKushidaa
doi : 10.1016/S1474-4422(21)00426-9
Volume 21, Issue 1, January 2022, Pages 15-17
Neurological infections in 2021: a spotlight on India
Ravindra KumarGargaHardeep SinghMalhotraaShwetaPandeya
doi : 10.1016/S1474-4422(21)00415-4
Volume 21, Issue 1, January 2022, Pages 17-18
Neuroscience in the 21st century: circuits, computation, and behaviour
Benjamin RKanteraChristine MLykkenaEdvard IMoseraMay-BrittMosera
doi : 10.1016/S1474-4422(21)00427-0
Volume 21, Issue 1, January 2022, Pages 19-21
Development of treatments for Down syndrome
Michael SRafiia
doi : 10.1016/S1474-4422(21)00411-7
Volume 21, Issue 1, January 2022, Pages 22-23
Risdiplam: new opportunities but more to be done
Valeria ASansoneab
doi : 10.1016/S1474-4422(21)00428-2
Volume 21, Issue 1, January 2022, Pages 23-24
Idiopathic hypersomnia: does first to approval mean first-line treatment?
Lynn MarieTrottia
doi : 10.1016/S1474-4422(21)00419-1
Volume 21, Issue 1, January 2022, Pages 25-26
Correction to Lancet Neurol 2021; 20: 762–72
doi : 10.1016/S1474-4422(21)00433-6
Volume 21, Issue 1, January 2022, Page e1
Correction to Lancet Neurol 2021; 20: 917–29
doi : 10.1016/S1474-4422(21)00434-8
Volume 21, Issue 1, January 2022, Page e1
Lars Edvinsson: bench-to-bedside discovery
UdaniSamarasekera
doi : 10.1016/S1474-4422(21)00323-9
Volume 21, Issue 1, January 2022, Page 27
50 years of intelligence gone
EmmanuelDrouinArnaudKwiatkowskiPatrickHautecoeur
doi : 10.1016/S1474-4422(21)00431-2
Volume 21, Issue 1, January 2022, Page 28
Vivid dreaming
JulesMorgan
doi : 10.1016/S1474-4422(21)00432-4
Volume 21, Issue 1, January 2022, Page 29
Following in the footsteps of neuroscience giants
PeterRanscombe
doi : 10.1016/S1474-4422(21)00362-8
Volume 21, Issue 1, January 2022, Page 30
Safety, efficacy, and tolerability of memantine for cognitive and adaptive outcome measures in adolescents and young adults with Down syndrome: a randomised, double-blind, placebo-controlled phase 2 trial
ProfAlberto C SCostaMDabAna CBrandãoMDdRichardBoadaPhDeVeridiana LBarrionuevoBSfProfHudson GTaylorPhDgElizabethRothPhDaMelissa RStaskoMAaMark WJohnsonPhDaFernanda FAssirMSdMaria PRobertoMSdPatríciaSalmonaMDfGuilhermeAbreu-SilveiraMDdIlyaBedermanPhDcErinPrendergastBScAnkeHülsPhDhiSarinaAbrishamcarBShZanMustacchiMDfThomasScheidemantelMDbProfNancy JRoizenMDaProfStephenRuedrichMDb
doi : 10.1016/S1474-4422(21)00369-0
Volume 21, Issue 1, January 2022, Pages 31-41
Safety and efficacy of once-daily risdiplam in type 2 and non-ambulant type 3 spinal muscular atrophy (SUNFISH part 2): a phase 3, double-blind, randomised, placebo-controlled trial
ProfEugenioMercuriMDaProfNicolasDeconinckMDbcElena SMazzonePTaAndresNascimentoMDdMaryamOskouiMDeProfKayokoSaitoMDfCaroleVuillerotMDghGiovanniBaranelloMDijProfOdileBoespflug-TanguyMDklProfNathalieGoemansMDmProfJanberndKirschnerMDnoProfAnnaKostera-PruszczykMDpProfLaurentServaisMDkqrMarianneGerberMDsKsenijaGorniMDsOmarKhwajaMDsuHeidemarieKletzlPhDsRenata SScalcoMDsHannahStauntonMSctWai YinYeungPhDtCarmenMartinPhDtPauloFontouraMDsProfJohn WDayMDvon behalf of the
doi : 10.1016/S1474-4422(21)00367-7
Volume 21, Issue 1, January 2022, Pages 42-52
Safety and efficacy of lower-sodium oxybate in adults with idiopathic hypersomnia: a phase 3, placebo-controlled, double-blind, randomised withdrawal study
ProfYvesDauvilliersMDabProfIsabelleArnulfMDcProfNancyFoldvary-SchaeferDOdAnne MarieMorseDOeProfKarelŠonkaMDfProfMichael JThorpyMDgProfEmmanuelMignotMDhPatriciaChandlerMDiRupaParvataneniMSiJedBlackMDijAmandaSterkelPhDiDanChenMDiFranckSkobierandaMDkRichard KBoganMDl
doi : 10.1016/S1474-4422(21)00368-9
Volume 21, Issue 1, January 2022, Pages 53-65
Blood-based biomarkers for Alzheimer's disease: towards clinical implementation
ProfCharlotte ETeunissenPhDaInge M WVerberkPhDaElisabeth HThijssenPhDaLisaVermuntPhDaProfOskarHanssonPhDdeProfHenrikZetterbergPhDfghijProfWiesje Mvan der FlierPhDbProfMichelle MMielkePhDkMartadel CampoPhDac
doi : 10.1016/S1474-4422(21)00361-6
Volume 21, Issue 1, January 2022, Pages 66-77
Sleep apnoea and ischaemic stroke: current knowledge and future directions
SébastienBaillieulPhDaceMartijnDekkersPhDaAnne-KathrinBrillMDbMarkus HSchmidtPhDagProfOlivierDetantePhDdfProfJean-LouisPépinceProfRenaudTamisierPhDceProfClaudio L ABassettiMDa
doi : 10.1016/S1474-4422(21)00321-5
Volume 21, Issue 1, January 2022, Pages 78-88
The neuropsychiatry of Parkinson's disease: advances and challenges
ProfDanielWeintraubMDabProfDagAarslandMDceProfKallol RayChaudhuriDSccdProfRoseanne DDobkinPhDfProfAlbert FGLeentjensMDgProfMayelaRodriguez-ViolanteMSchProfAnetteSchragPhDi
doi : 10.1016/S1474-4422(21)00330-6
Volume 21, Issue 1, January 2022, Pages 89-102
